Abstract-Transport of three different molecules across a porous membrane, with and without a confluent A549 cell monolayer, has been investigated in Transwells and microfluidic devices. The A549 cell line was selected since it has extensively been utilized in toxicology studies due to its potential target for drug delivery of macro molecules. The measured molecular transport rate was found to decrease with increasing molecular size due to lower diffusivity. The confluent cell monolayer presents a barrier to molecular, significantly reducing the transport rate of larger molecules with little effect on the paracellular transport of smaller molecules. The results indicate that the microfluidic system is a good model for pharmacokinetic applications.
I. INTRODUCTION
Developing new drugs is time consuming and expensive due in part to the poor success rate [1] . The development time for a single drug is estimated to be longer than 10 years, and only about 1 of 10,000 compounds tested is successful. Despite the efforts to evaluate a drug's potential efficacy and toxicity with screening tools early in the development process, many drugs fail during the later most expensive phases of drug development. Drugs typically fail due to lack of efficacy or toxic side effects especially in therapeutic areas, such as oncology, where the screening tools do not recreate the human metabolism properly. Traditional screening tools, such as in vitro cell-based assays and animal models, give a first indication of the efficacy and toxicity of a compound prior to its progression into clinical trials. However, in the human body, a drug undergoes complex processes that involve its absorption, distribution, metabolism, and elimination (ADME); these processes determine the concentration-time profiles in the various organs as well as in the bloodstream. Cell-based assays, therefore, often fail not only because they utilize immortalized cell lines with limited authentic cellular behavior, but also because they do not consider the complexity of the body with its multiple organs and their interactions. Animal models, on the other hand, do not always predict the action of drugs accurately because human metabolism can significantly differ from animal metabolism [2] . Thus, the advent of 'organ-onchips', in which human organ functions can be faithfully modeled in vitro, holds immense potential for drug development as they can potentially be used to extract physiologically relevant pharmacokinetic parameters for new compounds [3] [4] [5] .
Delivering drugs via the pulmonary system has been recognized as an attractive option due to its large absorptive area, extensive vasculature, and low extracellular and intracellular enzymatic activity [6] . Furthermore, pulmonary delivery allows for a practically instantaneous absorption of drug into the blood stream as well as local application of drugs in case of pulmonary disease. Local delivery of aerosolized medications to the lung, targeting the upper airway, is used to treat bronchoconstriction. However, in order to achieve adequate delivery to the circulatory system via the pulmonary route, a drug must reach the alveoli where diffusion and phagocytosis are considered to be the dominant drug-absorption mechanisms.
The alveolar epithelial lining, composed of Type I and Type II cells, is regarded as the major barrier to protein transport across the alveolar space. Type I cells cover the bulk of the surface area of the pulmonary epithelium and are unable to divide. Type II cells, while covering substantially less surface area of the alveolus, are more numerous and have distinct functions. The endocytic properties of Type II cells have been well characterized; they produce surfactant which is stored in lamellar bodies, and have been implicated in the oxidative metabolism of drugs in the lung. Hence, Type II pulmonary epithelial cells are a potential target for drug delivery of macromolecules.
Uptake and transport experiments of several molecules were conducted to characterize the A459 human lung adenocarcinoma cell line as an in vitro model of Type II alveolar epithelium. The results indicated that the cell line could be useful for studying the metabolic and macromoleculeprocessing contributions of alveolar Type II cells to mechanisms of drug delivery at the pulmonary epithelium [7] . An early permeability study suggested that peptides and proteins penetrate the A549 cell monolayer via a paracellular route by passive diffusion [8] . The A549 cell layer was also used as a model cancer cell line to investigate the effect of fluidic shear stress on cellular uptake in a microfluidic system mimicking the human dynamic environment. The results suggested that biomimetic dynamic conditions stimulated specific endocytosis and prompted cellular uptake. Thus, it is important to consider fluidic shear stress as one of the critical factors affecting cellular uptake and drug delivery [9] .
In this work, molecular transport across a cultured alveolar A549 cell monolayer is investigated in a microfluidic device designed similarly in concept to a biomimetic microsystem that reconstitutes the critical functional alveolar-capillary interface of the human lung [10] .
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II. EXPERIMENTAL ARRANGEMENTS
Experiments were conducted using the A549 human lung adenocarcinoma cell line (ATCC). The A549 cell line has characteristic features of pulmonary epithelium, which has a role in the oxidative metabolism of drugs in the lung. This cell line has indeed been extensively utilized in toxicology studies, including its properties on permeable supports, due to its potential target for drug delivery of macro-molecules [7] . Cells were maintained using RPMI 1640 medium with 10% fetal bovine serum and 1% penicillin streptomycin. For transport experiments through the epithelium, three different molecules were tested: Lucifer yellow (444 g/mol), FITC-transferrin (80,000g/mol), and FITC-dextran (70,000 g/mol) with their diffusivity in water about 3.1×10 -10 m 2 /s, 5.3×10 -11 m 2 /s and 3.3×10 -11 m 2 /s, respectively. Lucifer yellow and FITC-dextran were selected as they are used in standard monolayer permeability assays to determine the passage of small and large molecules through leaky intercellular junctions or paracellular transport. Specifically, a higher molecular weight dextran was used to serve as a synthetic analogue of a similar size as the FITC-transferrin. FITC-transferrin was used as it is a protein known for its uptake by the transferrin receptor on A549 cells and is typically used to mark transcellular transport. Two sets of transport experiments are reported here: (i) Transwells under static condition to eliminate the effect of shear stress, and (ii) microfluidic devices under fluid flow to account for the flowinduced shear stress. 
A. Transwell Experiments
A schematic set-up of the Transwell experiments is drawn in Figure 1 . A549 cells were plated at a cell density of 2×10 6 cells/mL on the polyester membrane separating the top and bottom compartments with a porosity of 0.3%. Microscopic bright-field images of the resulting confluent monolayers after 1 and 8 days culture are shown in Figure 2 . The cell surface density appears to be about the same indicating the development of stable cellular morphology after one day of cell culture. The A549 cell monolayers were exposed for two hours to static fluorescent solutions diluted in regular cell media in the upper Transwell compartment. Afterwards the media in both compartments was removed and the fluorescent intensity of each sample was measured to evaluate the molecular transport. To calculate relative concentration, the fluorescent intensity of the samples was normalized by the initial intensity measured in the upper compartment at the start of each experiment. The monolayer integrity was evaluated at the end of each experiment to ensure no decrease in cell confluence due to the molecular transport. Each trial was performed on a fresh monolayer in a new Transwell to ensure no residual fluorescent molecules would skew the measurements. 
B. Microfluidic Device Experiments
Experiments were also conducted in a microfluidic device under constant flow rate. The device was fabricated using soft lithography techniques. An aluminum mold, featuring two microchannels about 500μm×1mm×4cm in dimensions, was covered with biocompatible polymer polydimethylsiloxane (PDMS) and allowed to cure overnight at 55°C. A porous polyester membrane to separate the microchannels was treated in an oxygen-plasma reactor and then submerged in a 5% APTES (3-Aminopropyl triethoxysilane) solution and cured at 55°C for 30 minutes to allow for an organosilane coating to form. The organosilane layer is necessary in creating a bond between the polyester and PDMS [11] . The membrane used had a porosity of 1.0%. To create an irreversible bonding between the device components, the PDMS bonding surfaces were also plasma treated for 60 seconds, and then bonded together with the membrane sandwiched between them. An image of a fabricated device is shown in Figure 3 . A549 cells were seeded at a density of 2×10 6 cells/mL in the upper channel developing into a confluent monolayer, shown in Figure 4 , within one post-seeding day. Molecular solutions were driven through the top channel at a 20 μL/hr flow rate, while driving regular cell media at the same flow rate through the bottom channel. Steady-state results were obtained by collecting 100μL samples of the outlet flow from each channel exit and measuring their fluorescent intensity using a BioTek Synergy 2 Well Plate Reader. Intensity measurements for lucifer yellow were performed using an excitation wavelength of 460 nm and emission wavelength of 528 nm. Intensity measurements for FITC-transferrin and FITC-dextran were done at an excitation wavelength of 485 nm and an emission of 528 nm. Relative concentration was calculated by normalizing by the total fluorescent intensity measured in the two channels. 
III. RESULTS AND ANALYSIS

A. Transwell Results
Lucifer yellow was introduced into the Transwell uppercompartment at a relatively high concentration of 100 μM to allow for more accurate measurements. The transport of Lucifer yellow from the upper to the lower compartment, through the A549 cell monolayer and its underlying porous membrane, was evaluated as a function of post-seeding days of cell culture. As shown in Figure 5 , the concentration measured at the lower compartment changed very little as a function of post-seeding time indicating stable cellular morphology.
The transport of the three molecules was investigated 72 hours after seeding, with and without the A459 cells, and the results are summarized in Figure 6 . As expected, the concentration following 2-hours of diffusion time, decreases with increasing molecular size due to lower diffusivity. Furthermore, the presence of the cellular monolayer clearly creates an additional transport barrier to all three types of molecules leading to a significantly lower concentration. In particular, the measured dextran concentration is within the background noise indicating practically no transport through the A549 cell layer. This means that the intercellular junctions in the confluent layer are very tight effectively blocking the paracellular transport. Since the transcellular transport is also blocked, as A549 cells do not uptake dextran, its concentration in the Transwell lower-compartment vanishes. In contrast, the concentration of transferrin is slightly higher. The molecular size and diffusivity of transferrin is about the same as dextran; therefore, one can assume that the paracellular transport of both molecule types is blocked. Since transferrin is known for its uptake by A549 cells, the transferrin concentration measured at the Transwell lower-compartment is most likely due to transcellular transport. The concentration of Lucifer yellow though is very high in comparison with both dextran and transferrin. Since A549 cells do not uptake Lucifer yellow either, it can be transported only via the paracellular route. Hence, it seems that while the intercellular junctions of the confluent A549 cell layer are tight enough to prevent transport of large molecules, they are leaky against small molecules. 
B. Microfluidic Device Results
Lucifer yellow mixed in media solution at a concentration of 100 μM was driven through the upper microchannel in the microfluidic device at a flow rate of 20μL/hr using a syringe pump. The transport of Lucifer yellow from the upper to the lower microchannel, through the A549 cell monolayer and the porous separation membrane, reaches a steady state as a balance between convection and diffusion. The resulting steady concentration at the bottom-channel exit was measured and No Cells A549 Cells plotted in Figure 7 as a function of post-seeding time of the A549 cells. Unlike the Transwell case, the concentration decreases slightly with increasing number of post-seeding days perhaps due to the formation of multiple layers of cells within the microchannel. Without cells, Figure 8 , the concentration of the three molecules in the lower channel decreases with increasing molecular size due to lower diffusivity consistent with the Traswell results. The low concentration of transferrin indicates minimal transcellular transport through the confluent A549 cell monolayer, while the low dextran concentration indicates a closely packed monolayer inhibiting paracellular transport. However, the transport of Lucifer yellow increases slightly perhaps due to the shear stress effect. Indeed, it has previously been reported that shear stress increases the endocytosis of small molecules [12] . The results suggest that although Lucifer yellow is typically used as a marker for paracellular transport, the applied shear stress may induce the A549 cells to uptake Lucifer yellow and transport it across the cell monolayer via the transcellular route. 
IV. CONCLUSIONS
The present microfluidic system, featuring two microchannels separated by a porous membrane, can be utilized for the evaluation of pharmacokinetic parameters. An A549 cell monolayer can be cultured to full confluence in the microfluidic device preventing the passage of large molecules similar to monolayers grown on Transwell supports. However, when the A549 monolayers are exposed in the microfluidic device to flow-induced shear stress the transport of small molecules like Lucifer yellow slightly increased when compared to the transport with no cells is a stark contrast to the behavior observed in monolayers on Transwells. This suggests that the shear stress is an essential element to be considered in selecting models for drug delivery studies. No Cells A549 Cells
